Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: Theoretical and practical implications

Virchows Archiv

Volumn 437, Issue 3, 2000, Pages 227-233

  Milde Langosch, Karin ^a   Riethdorf, Sabine ^a   Loning T ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cervical cancer; Cervical dysplasia; HPV

Indexed keywords

CANCER SCREENING; CARCINOGENESIS; DISEASE ASSOCIATION; DYSPLASIA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033829093     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000234     Document Type: Review

References (72)

1. Determination of genital human papillomavirus infection by consensus PCR amplification
2. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture
3. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
4. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
5. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri
6. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect routine high-grade cervical lesions: A preliminary study on 1518 women
7. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens
8. HPV testing by hybrid capture is useful in triaging women with a cytologic diagnosis of ASQUS
9. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
10. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia
11. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
12. The use of general primers GP5 and GP6 elongated at their 3'-ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
13. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization
14. Identification of the alpha 6 integrin as a candidate receptor for papillomaviruses
15. Meta-analysis of Pap test accuracy
16. Viral testing for genital human papillomavirus infections: Recent progress and clinical potential
17. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses
18. Persistence of type specific human papillomavirus infection among cytomorphologically normal women
19. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
20. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia
21. Natural history of cervicovaginal papillomavirus infection in young women
22. Human papillomavirus DNA in distant metastases of cervical cancer
23. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer- mediated PCR and two cocktails of oligonucleotide probes
24. A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
25. Organotypic culture of HPV-transformed keratinocytes: A model for testing lymphocyte infiltration of (pre)neoplastic lesions of the uterine cervix
26. Is human papillomavirus testing of value in clinical practice?
27. Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasias: Implications for current views and treatment
28. Monocyte-chemo-attractant protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas
29. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses
30. Telomerase activation by the E6 gene product of human papillomavirus type 16
31. The molecular genetics of cervical carcinoma
32. Determinants of genital human papillomavirus infection in young women
33. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
34. Papillomaviruses and cervical cancer: Pathogenesis and vaccine development
35. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses
36. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YYI
37. HPV typing and testing in gynaecological pathology: Has the time come?
38. Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe
39. Human papillomavirus detection in cervical adenocarcinomas by polymerase chain reaction
40. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva
41. Naturlicher Verlauf der HPV-Infektion. Nutzen der HPV-Analytik in der Zervixdiagnostik
42. ErbB2 (Her2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix
43. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection
44. Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes
45. Relation of human papillomavirus status to the cervical lesions and consequences for cervical-cancer screening: A prospective study
46. Viral sequences related to a human skin papillomavirus in genital warts
47. Molecular biology of cervical cancer and its precursors
48. Correlation between HPV type and clonal status of cervical squamous intraepithelial lesions (SIL)
49. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix
50. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?
51. Differential expression of the monocyte chemoattractant protein-I gene in human papillomavirus 16-infected squamous intraepithelial lesions and squamous cell carcinomas of the Cervix uteri
52. Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases
53. Differences in HPV 16 and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinoma of the cervix uteri
54. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri
55. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
56. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cell lines and derived hybrids
57. Expression of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions
58. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasias
59. The epidemiology of cervical carcinogenesis
60. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16
61. Towards objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high-risk papillomavirus types
62. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
63. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
64. The structure, function and regulation of papillomaviral genes in infection and cervical cancer
65. Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein
66. Human papillomavirus in false negative archival cervical smears: Implications for screening for cervical cancer
67. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
68. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation
69. Cell-cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7
70. Inactivation of the cdk inhibitor p27kip1 by the human papillomavirus type 16 E7 oncoprotein
71. Papillomavirus infections and human genital cancer
72. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types